APO Research
Talk to an analyst

APO RESEARCH · REPORT

Trastuzumab Biosimilar

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Trastuzumab Biosimilar Industry Growth and Trends Forecast to 2032

31 December 2025102 pages

Choose your research edition.

Industry ResearchTrastuzumab Biosimilar Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Trastuzumab Biosimilar Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Trastuzumab Biosimilar Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Trastuzumab Biosimilar Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Trastuzumab Biosimilar Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Trastuzumab Biosimilar market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Trastuzumab Biosimilar is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Trastuzumab Biosimilar is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Trastuzumab Biosimilar is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Trastuzumab Biosimilar include Mundipharma, Samsung Bioepis, Amgen Inc., Biocon Limited, Henlius, Pfizer Inc, Genentech, Merck & Co. and Celltrion, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Trastuzumab Biosimilar market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Trastuzumab Biosimilar market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Trastuzumab Biosimilar market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Trastuzumab Biosimilar.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Trastuzumab Biosimilar market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Trastuzumab Biosimilar Market by Company

Mundipharma

Samsung Bioepis

Amgen Inc.

Biocon Limited

Henlius

Pfizer Inc

Genentech

Merck & Co.

Celltrion

Teva Pharmaceutical

Trastuzumab Biosimilar Segment by Type

Adjuvant Breast Cancer

Metastatic Breast Cancer

Metastatic Gastric Cancer

Others

Trastuzumab Biosimilar Segment by Application

Hospital Pharmacy

Online Pharmacy

Trastuzumab Biosimilar Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Trastuzumab Biosimilar market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Trastuzumab Biosimilar and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Trastuzumab Biosimilar.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Trastuzumab Biosimilar manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Trastuzumab Biosimilar in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Adjuvant Breast Cancer Table 2. Major Company of Metastatic Breast Cancer Table 3. Major Company of Metastatic Gastric Cancer Table 4. Major Company of Others Table 5. Global Trastuzumab Biosimilar Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Trastuzumab Biosimilar Sales by Type (2021-2026) & (K Units) Table 7. Global Trastuzumab Biosimilar Sales Market Share in Volume by Type (2021-2026) Table 8. Global Trastuzumab Biosimilar Sales by Type (2021-2026) & (US$ Million) Table 9. Global Trastuzumab Biosimilar Sales Market Share in Value by Type (2021-2026) Table 10. Global Trastuzumab Biosimilar Price by Type (2021-2026) & (US$/Unit) Table 11. Global Trastuzumab Biosimilar Sales by Type (2027-2032) & (K Units) Table 12. Global Trastuzumab Biosimilar Sales Market Share in Volume by Type (2027-2032) Table 13. Global Trastuzumab Biosimilar Sales by Type (2027-2032) & (US$ Million) Table 14. Global Trastuzumab Biosimilar Sales Market Share in Value by Type (2027-2032) Table 15. Global Trastuzumab Biosimilar Price by Type (2027-2032) & (US$/Unit) Table 16. North America Trastuzumab Biosimilar Sales by Type (2021-2026) & (K Units) Table 17. North America Trastuzumab Biosimilar Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Trastuzumab Biosimilar Sales by Type (2021-2026) & (K Units) Table 19. Europe Trastuzumab Biosimilar Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Trastuzumab Biosimilar Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Trastuzumab Biosimilar Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Trastuzumab Biosimilar Sales by Type (2021-2026) & (K Units) Table 23. Latin America Trastuzumab Biosimilar Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Trastuzumab Biosimilar Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Trastuzumab Biosimilar Sales by Type (2021-2026) & (US$ Million) Table 26. Trastuzumab Biosimilar Industry Trends Table 27. Trastuzumab Biosimilar Industry Drivers Table 28. Trastuzumab Biosimilar Industry Opportunities and Challenges Table 29. Trastuzumab Biosimilar Industry Restraints Table 30. Global Trastuzumab Biosimilar Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Trastuzumab Biosimilar Revenue Market Share by Company (2021-2026) Table 32. Global Trastuzumab Biosimilar Sales by Company (2021-2026) & (K Units) Table 33. Global Trastuzumab Biosimilar Sales Share by Company (2021-2026) Table 34. Global Trastuzumab Biosimilar Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Trastuzumab Biosimilar Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Trastuzumab Biosimilar Major Company Production Sites and Headquarters Table 37. Global Trastuzumab Biosimilar Company, Product Type & Application Table 38. Global Trastuzumab Biosimilar Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Trastuzumab Biosimilar by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Trastuzumab Biosimilar Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Trastuzumab Biosimilar Sales by Region (2021-2026) & (K Units) Table 43. Global Trastuzumab Biosimilar Sales Market Share in Volume by Region (2021-2026) Table 44. Global Trastuzumab Biosimilar Sales by Region (2021-2026) & (US$ Million) Table 45. Global Trastuzumab Biosimilar Sales Market Share in Value by Region (2021-2026) Table 46. Global Trastuzumab Biosimilar Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Trastuzumab Biosimilar Sales by Region (2027-2032) & (K Units) Table 48. Global Trastuzumab Biosimilar Sales Market Share in Volume by Region (2027-2032) Table 49. Global Trastuzumab Biosimilar Sales by Region (2027-2032) & (US$ Million) Table 50. Global Trastuzumab Biosimilar Sales Market Share in Value by Region (2027-2032) Table 51. Global Trastuzumab Biosimilar Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Trastuzumab Biosimilar Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Trastuzumab Biosimilar Sales by Application (2021-2026) & (K Units) Table 54. Global Trastuzumab Biosimilar Sales Market Share in Volume by Application (2021-2026) Table 55. Global Trastuzumab Biosimilar Sales by Application (2021-2026) & (US$ Million) Table 56. Global Trastuzumab Biosimilar Sales Market Share in Value by Application (2021-2026) Table 57. Global Trastuzumab Biosimilar Price by Application (2021-2026) & (US$/Unit) Table 58. Global Trastuzumab Biosimilar Sales by Application (2027-2032) & (K Units) Table 59. Global Trastuzumab Biosimilar Sales Market Share in Volume by Application (2027-2032) Table 60. Global Trastuzumab Biosimilar Sales by Application (2027-2032) & (US$ Million) Table 61. Global Trastuzumab Biosimilar Sales Market Share in Value by Application (2027-2032) Table 62. Global Trastuzumab Biosimilar Price by Application (2027-2032) & (US$/Unit) Table 63. North America Trastuzumab Biosimilar Sales by Application (2021-2026) & (K Units) Table 64. North America Trastuzumab Biosimilar Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Trastuzumab Biosimilar Sales by Application (2021-2026) & (K Units) Table 66. Europe Trastuzumab Biosimilar Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Trastuzumab Biosimilar Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Trastuzumab Biosimilar Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Trastuzumab Biosimilar Sales by Application (2021-2026) & (K Units) Table 70. Latin America Trastuzumab Biosimilar Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Trastuzumab Biosimilar Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Trastuzumab Biosimilar Sales by Application (2021-2026) & (US$ Million) Table 73. Mundipharma Company Information Table 74. Mundipharma Business Overview Table 75. Mundipharma Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Mundipharma Trastuzumab Biosimilar Product Portfolio Table 77. Mundipharma Recent Development Table 78. Samsung Bioepis Company Information Table 79. Samsung Bioepis Business Overview Table 80. Samsung Bioepis Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Samsung Bioepis Trastuzumab Biosimilar Product Portfolio Table 82. Samsung Bioepis Recent Development Table 83. Amgen Inc. Company Information Table 84. Amgen Inc. Business Overview Table 85. Amgen Inc. Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Amgen Inc. Trastuzumab Biosimilar Product Portfolio Table 87. Amgen Inc. Recent Development Table 88. Biocon Limited Company Information Table 89. Biocon Limited Business Overview Table 90. Biocon Limited Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Biocon Limited Trastuzumab Biosimilar Product Portfolio Table 92. Biocon Limited Recent Development Table 93. Henlius Company Information Table 94. Henlius Business Overview Table 95. Henlius Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Henlius Trastuzumab Biosimilar Product Portfolio Table 97. Henlius Recent Development Table 98. Pfizer Inc Company Information Table 99. Pfizer Inc Business Overview Table 100. Pfizer Inc Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Pfizer Inc Trastuzumab Biosimilar Product Portfolio Table 102. Pfizer Inc Recent Development Table 103. Genentech Company Information Table 104. Genentech Business Overview Table 105. Genentech Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Genentech Trastuzumab Biosimilar Product Portfolio Table 107. Genentech Recent Development Table 108. Merck & Co. Company Information Table 109. Merck & Co. Business Overview Table 110. Merck & Co. Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Merck & Co. Trastuzumab Biosimilar Product Portfolio Table 112. Merck & Co. Recent Development Table 113. Celltrion Company Information Table 114. Celltrion Business Overview Table 115. Celltrion Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Celltrion Trastuzumab Biosimilar Product Portfolio Table 117. Celltrion Recent Development Table 118. Teva Pharmaceutical Company Information Table 119. Teva Pharmaceutical Business Overview Table 120. Teva Pharmaceutical Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Teva Pharmaceutical Trastuzumab Biosimilar Product Portfolio Table 122. Teva Pharmaceutical Recent Development Table 123. North America Trastuzumab Biosimilar Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 124. North America Trastuzumab Biosimilar Sales by Country (2021-2026) & (K Units) Table 125. North America Trastuzumab Biosimilar Sales Market Share by Country (2021-2026) Table 126. North America Trastuzumab Biosimilar Sales Forecast by Country (2027-2032) & (K Units) Table 127. North America Trastuzumab Biosimilar Sales Market Share Forecast by Country (2027-2032) Table 128. North America Trastuzumab Biosimilar Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Trastuzumab Biosimilar Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Trastuzumab Biosimilar Market Share by Country (2021-2026) Table 131. North America Trastuzumab Biosimilar Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Trastuzumab Biosimilar Market Share Forecast by Country (2027-2032) Table 133. Europe Trastuzumab Biosimilar Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. Europe Trastuzumab Biosimilar Sales by Country (2021-2026) & (K Units) Table 135. Europe Trastuzumab Biosimilar Sales Market Share by Country (2021-2026) Table 136. Europe Trastuzumab Biosimilar Sales Forecast by Country (2027-2032) & (K Units) Table 137. Europe Trastuzumab Biosimilar Sales Market Share Forecast by Country (2027-2032) Table 138. Europe Trastuzumab Biosimilar Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Trastuzumab Biosimilar Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Trastuzumab Biosimilar Market Share by Country (2021-2026) Table 141. Europe Trastuzumab Biosimilar Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Trastuzumab Biosimilar Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Trastuzumab Biosimilar Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Trastuzumab Biosimilar Sales by Country (2021-2026) & (K Units) Table 145. Asia-Pacific Trastuzumab Biosimilar Sales Market Share by Country (2021-2026) Table 146. Asia-Pacific Trastuzumab Biosimilar Sales Forecast by Country (2027-2032) & (K Units) Table 147. Asia-Pacific Trastuzumab Biosimilar Sales Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Trastuzumab Biosimilar Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Trastuzumab Biosimilar Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Trastuzumab Biosimilar Market Share by Country (2021-2026) Table 151. Asia-Pacific Trastuzumab Biosimilar Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Trastuzumab Biosimilar Market Share Forecast by Country (2027-2032) Table 153. Latin America Trastuzumab Biosimilar Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 154. Latin America Trastuzumab Biosimilar Sales by Country (2021-2026) & (K Units) Table 155. Latin America Trastuzumab Biosimilar Sales Market Share by Country (2021-2026) Table 156. Latin America Trastuzumab Biosimilar Sales Forecast by Country (2027-2032) & (K Units) Table 157. Latin America Trastuzumab Biosimilar Sales Market Share Forecast by Country (2027-2032) Table 158. Latin America Trastuzumab Biosimilar Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Trastuzumab Biosimilar Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Trastuzumab Biosimilar Market Share by Country (2021-2026) Table 161. Latin America Trastuzumab Biosimilar Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Trastuzumab Biosimilar Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Trastuzumab Biosimilar Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Trastuzumab Biosimilar Sales by Country (2021-2026) & (K Units) Table 165. Middle East and Africa Trastuzumab Biosimilar Sales Market Share by Country (2021-2026) Table 166. Middle East and Africa Trastuzumab Biosimilar Sales Forecast by Country (2027-2032) & (K Units) Table 167. Middle East and Africa Trastuzumab Biosimilar Sales Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Trastuzumab Biosimilar Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Trastuzumab Biosimilar Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East and Africa Trastuzumab Biosimilar Market Share by Country (2021-2026) Table 171. Middle East and Africa Trastuzumab Biosimilar Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East and Africa Trastuzumab Biosimilar Market Share Forecast by Country (2027-2032) Table 173. Key Raw Materials Table 174. Raw Materials Key Suppliers Table 175. Trastuzumab Biosimilar Distributors List Table 176. Trastuzumab Biosimilar Customers List Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. Trastuzumab Biosimilar Image Figure 2. Global Trastuzumab Biosimilar Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Trastuzumab Biosimilar Market Size (2021-2032) & (US$ Million) Figure 4. Global Trastuzumab Biosimilar Sales (2021-2032) & (K Units) Figure 5. Adjuvant Breast Cancer Image Figure 6. Global Adjuvant Breast Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 7. Metastatic Breast Cancer Image Figure 8. Global Metastatic Breast Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 9. Metastatic Gastric Cancer Image Figure 10. Global Metastatic Gastric Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Trastuzumab Biosimilar Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Trastuzumab Biosimilar Market Share by Type 2025 VS 2032 Figure 15. North America Trastuzumab Biosimilar Sales Market Share in Volume by Type in 2025 Figure 16. North America Trastuzumab Biosimilar Sales Market Share in Value by Type in 2025 Figure 17. Europe Trastuzumab Biosimilar Sales Market Share in Volume by Type in 2025 Figure 18. Europe Trastuzumab Biosimilar Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Trastuzumab Biosimilar Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Trastuzumab Biosimilar Sales Market Share in Value by Type in 2025 Figure 21. Latin America Trastuzumab Biosimilar Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Trastuzumab Biosimilar Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Trastuzumab Biosimilar Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Trastuzumab Biosimilar Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Trastuzumab Biosimilar Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Pharmacy Image Figure 28. Global Hospital Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 29. Online Pharmacy Image Figure 30. Global Online Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Trastuzumab Biosimilar Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Trastuzumab Biosimilar Market Share by Application 2025 VS 2032 Figure 33. North America Trastuzumab Biosimilar Sales Market Share in Volume by Application in 2025 Figure 34. North America Trastuzumab Biosimilar Sales Market Share in Value by Application in 2025 Figure 35. Europe Trastuzumab Biosimilar Sales Market Share in Volume by Application in 2025 Figure 36. Europe Trastuzumab Biosimilar Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Trastuzumab Biosimilar Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Trastuzumab Biosimilar Sales Market Share in Value by Application in 2025 Figure 39. Latin America Trastuzumab Biosimilar Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Trastuzumab Biosimilar Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Trastuzumab Biosimilar Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Trastuzumab Biosimilar Sales Market Share in Value by Application in 2025 Figure 43. North America Trastuzumab Biosimilar Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Trastuzumab Biosimilar Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Trastuzumab Biosimilar Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Trastuzumab Biosimilar Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Trastuzumab Biosimilar Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Trastuzumab Biosimilar Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Trastuzumab Biosimilar Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Trastuzumab Biosimilar Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Trastuzumab Biosimilar Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Trastuzumab Biosimilar Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Trastuzumab Biosimilar Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Trastuzumab Biosimilar Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Trastuzumab Biosimilar Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Trastuzumab Biosimilar Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Trastuzumab Biosimilar Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Trastuzumab Biosimilar Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Trastuzumab Biosimilar Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Trastuzumab Biosimilar Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Trastuzumab Biosimilar Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Trastuzumab Biosimilar Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Trastuzumab Biosimilar Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Trastuzumab Biosimilar Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Adjuvant Breast Cancer
  • Metastatic Breast Cancer
  • Metastatic Gastric Cancer
  • Others
Applications
  • Hospital Pharmacy
  • Online Pharmacy
Companies covered
  • Mundipharma
  • Samsung Bioepis
  • Amgen Inc.
  • Biocon Limited
  • Henlius
  • Pfizer Inc
  • Genentech
  • Merck & Co.
  • Celltrion
  • Teva Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Trastuzumab Biosimilar Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Trastuzumab Biosimilar Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Trastuzumab Biosimilar Market by Type
  6. 1.3.1 Adjuvant Breast Cancer
  7. 1.3.2 Metastatic Breast Cancer
  8. 1.3.3 Metastatic Gastric Cancer
  9. 1.3.4 Others
  10. 1.4 Global Trastuzumab Biosimilar Market Size by Type
  11. 1.4.1 Global Trastuzumab Biosimilar Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Trastuzumab Biosimilar Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Trastuzumab Biosimilar Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Trastuzumab Biosimilar Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Trastuzumab Biosimilar Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Trastuzumab Biosimilar Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Trastuzumab Biosimilar Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Trastuzumab Biosimilar Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Trastuzumab Biosimilar Industry Trends
  2. 2.2 Trastuzumab Biosimilar Industry Drivers
  3. 2.3 Trastuzumab Biosimilar Industry Opportunities and Challenges
  4. 2.4 Trastuzumab Biosimilar Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Trastuzumab Biosimilar Revenue (2021-2026)
  2. 3.2 Global Top Players by Trastuzumab Biosimilar Sales (2021-2026)
  3. 3.3 Global Top Players by Trastuzumab Biosimilar Price (2021-2026)
  4. 3.4 Global Trastuzumab Biosimilar Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Trastuzumab Biosimilar Major Company Production Sites & Headquarters
  6. 3.6 Global Trastuzumab Biosimilar Company, Product Type & Application
  7. 3.7 Global Trastuzumab Biosimilar Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Trastuzumab Biosimilar Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Trastuzumab Biosimilar Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Trastuzumab Biosimilar Tier 1, Tier 2, and Tier 3
4 Trastuzumab Biosimilar Regional Status and Outlook
  1. 4.1 Global Trastuzumab Biosimilar Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Trastuzumab Biosimilar Historic Market Size by Region
  3. 4.2.1 Global Trastuzumab Biosimilar Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Trastuzumab Biosimilar Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Trastuzumab Biosimilar Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Trastuzumab Biosimilar Forecasted Market Size by Region
  7. 4.3.1 Global Trastuzumab Biosimilar Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Trastuzumab Biosimilar Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Trastuzumab Biosimilar Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Trastuzumab Biosimilar by Application
  1. 5.1 Trastuzumab Biosimilar Market by Application
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.2 Global Trastuzumab Biosimilar Market Size by Application
  5. 5.2.1 Global Trastuzumab Biosimilar Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Trastuzumab Biosimilar Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Trastuzumab Biosimilar Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Trastuzumab Biosimilar Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Trastuzumab Biosimilar Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Trastuzumab Biosimilar Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Trastuzumab Biosimilar Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Trastuzumab Biosimilar Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Mundipharma
  2. 6.1.1 Mundipharma Company Information
  3. 6.1.2 Mundipharma Business Overview
  4. 6.1.3 Mundipharma Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Mundipharma Trastuzumab Biosimilar Product Portfolio
  6. 6.1.5 Mundipharma Recent Developments
  7. 6.2 Samsung Bioepis
  8. 6.2.1 Samsung Bioepis Company Information
  9. 6.2.2 Samsung Bioepis Business Overview
  10. 6.2.3 Samsung Bioepis Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Samsung Bioepis Trastuzumab Biosimilar Product Portfolio
  12. 6.2.5 Samsung Bioepis Recent Developments
  13. 6.3 Amgen Inc.
  14. 6.3.1 Amgen Inc. Company Information
  15. 6.3.2 Amgen Inc. Business Overview
  16. 6.3.3 Amgen Inc. Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Amgen Inc. Trastuzumab Biosimilar Product Portfolio
  18. 6.3.5 Amgen Inc. Recent Developments
  19. 6.4 Biocon Limited
  20. 6.4.1 Biocon Limited Company Information
  21. 6.4.2 Biocon Limited Business Overview
  22. 6.4.3 Biocon Limited Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Biocon Limited Trastuzumab Biosimilar Product Portfolio
  24. 6.4.5 Biocon Limited Recent Developments
  25. 6.5 Henlius
  26. 6.5.1 Henlius Company Information
  27. 6.5.2 Henlius Business Overview
  28. 6.5.3 Henlius Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Henlius Trastuzumab Biosimilar Product Portfolio
  30. 6.5.5 Henlius Recent Developments
  31. 6.6 Pfizer Inc
  32. 6.6.1 Pfizer Inc Company Information
  33. 6.6.2 Pfizer Inc Business Overview
  34. 6.6.3 Pfizer Inc Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Inc Trastuzumab Biosimilar Product Portfolio
  36. 6.6.5 Pfizer Inc Recent Developments
  37. 6.7 Genentech
  38. 6.7.1 Genentech Company Information
  39. 6.7.2 Genentech Business Overview
  40. 6.7.3 Genentech Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Genentech Trastuzumab Biosimilar Product Portfolio
  42. 6.7.5 Genentech Recent Developments
  43. 6.8 Merck & Co.
  44. 6.8.1 Merck & Co. Company Information
  45. 6.8.2 Merck & Co. Business Overview
  46. 6.8.3 Merck & Co. Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Merck & Co. Trastuzumab Biosimilar Product Portfolio
  48. 6.8.5 Merck & Co. Recent Developments
  49. 6.9 Celltrion
  50. 6.9.1 Celltrion Company Information
  51. 6.9.2 Celltrion Business Overview
  52. 6.9.3 Celltrion Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Celltrion Trastuzumab Biosimilar Product Portfolio
  54. 6.9.5 Celltrion Recent Developments
  55. 6.10 Teva Pharmaceutical
  56. 6.10.1 Teva Pharmaceutical Company Information
  57. 6.10.2 Teva Pharmaceutical Business Overview
  58. 6.10.3 Teva Pharmaceutical Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Teva Pharmaceutical Trastuzumab Biosimilar Product Portfolio
  60. 6.10.5 Teva Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Trastuzumab Biosimilar Sales by Country
  2. 7.1.1 North America Trastuzumab Biosimilar Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Trastuzumab Biosimilar Sales by Country (2021-2026)
  4. 7.1.3 North America Trastuzumab Biosimilar Sales Forecast by Country (2027-2032)
  5. 7.2 North America Trastuzumab Biosimilar Market Size by Country
  6. 7.2.1 North America Trastuzumab Biosimilar Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Trastuzumab Biosimilar Market Size by Country (2021-2026)
  8. 7.2.3 North America Trastuzumab Biosimilar Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Trastuzumab Biosimilar Sales by Country
  2. 8.1.1 Europe Trastuzumab Biosimilar Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Trastuzumab Biosimilar Sales by Country (2021-2026)
  4. 8.1.3 Europe Trastuzumab Biosimilar Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Trastuzumab Biosimilar Market Size by Country
  6. 8.2.1 Europe Trastuzumab Biosimilar Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Trastuzumab Biosimilar Market Size by Country (2021-2026)
  8. 8.2.3 Europe Trastuzumab Biosimilar Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Trastuzumab Biosimilar Sales by Country
  2. 9.1.1 Asia-Pacific Trastuzumab Biosimilar Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Trastuzumab Biosimilar Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Trastuzumab Biosimilar Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Trastuzumab Biosimilar Market Size by Country
  6. 9.2.1 Asia-Pacific Trastuzumab Biosimilar Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Trastuzumab Biosimilar Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Trastuzumab Biosimilar Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Trastuzumab Biosimilar Sales by Country
  2. 10.1.1 South America Trastuzumab Biosimilar Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Trastuzumab Biosimilar Sales by Country (2021-2026)
  4. 10.1.3 South America Trastuzumab Biosimilar Sales Forecast by Country (2027-2032)
  5. 10.2 South America Trastuzumab Biosimilar Market Size by Country
  6. 10.2.1 South America Trastuzumab Biosimilar Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Trastuzumab Biosimilar Market Size by Country (2021-2026)
  8. 10.2.3 South America Trastuzumab Biosimilar Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Trastuzumab Biosimilar Sales by Country
  2. 11.1.1 Middle East and Africa Trastuzumab Biosimilar Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Trastuzumab Biosimilar Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Trastuzumab Biosimilar Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Trastuzumab Biosimilar Market Size by Country
  6. 11.2.1 Middle East and Africa Trastuzumab Biosimilar Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Trastuzumab Biosimilar Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Trastuzumab Biosimilar Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Trastuzumab Biosimilar Value Chain Analysis
  2. 12.1.1 Trastuzumab Biosimilar Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Trastuzumab Biosimilar Production Mode & Process
  7. 12.2 Trastuzumab Biosimilar Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Trastuzumab Biosimilar Distributors
  10. 12.2.3 Trastuzumab Biosimilar Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst